IL1B and colorectal carcinoma: Consistently, the inhibition of gut inflammation can significantly protect against intestinal barrier damage and inhibit CRC.[49, 50] Notably, our studies showed that GA treatment can significantly inhibit the expression of pro‐inflammatory cytokines IL‐1β, IL‐6, and TNF‐α in UC mice and intestinal organoids.